InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Pomerantz Roger, Director. Officer active across 2 companies, notably Viracta Therapeutics, Inc.. In total, 13 filings have been recorded. Activity tracked since 25 November 2021. The latest transaction was filed on 25 November 2024 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations
Pomerantz Roger is Administrateur at Viracta Therapeutics, Inc. The 13 filings on record, all included in the recent sampled filings, cover the period from 2021-11-29 to 2024-11-27. The most frequent transaction nature shown is Levée d'options, and the reported buy and sell amounts are 0 and 0.